Purpose: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), potentially life-threatening skin diseases with organ failures caused by drugs, require specialized intensive care. However, SJS and TEN have usually been managed in general wards and intensive care units by most doctors. This study describes the efficacy of treatment in the burn intensive care unit (BICU) compared to previous general treatments. Methods: To investigate the clinical features, outcomes and benefits of 11 patients with SJS and TEN treated in our burn intensive care unit. Data on 11 patients who were treated between January 2004 and December 2008 were collected via a retrospective chart review. Also, the data were reviewed with previous literatures on SJS and TEN treatments. Results: Patients were classified with overlap SJS/TEN (n=4, 36.36%) or TEN (n=7, 63.64%). Nonsteroidal anti-inflammatory drugs (NSAIDs) were the most common causative agents. Hepatitis was the most common organ involvement in both overlap SJS/TEN (n=1, 9.1%) and TEN (n=4, 36.36%). Renal dysfunction (n=4, 36.36%) and respiratory disorders (n=3, 27.27%) were seen in some cases. Mean time of total reepithelization was 9 days and mean hospital day was 14.66 days. Two patients with TEN died from sepsis with multi-organ failure, and the mortality rate was 18.18%. Conclusion: Adequate treatment of SJS and TEN in the BICU supports efficacy with a low mortality rate, short healing time, short hospitalization and fewer complications. 
Herein, we report our interesting retrospective study in treating SJS and TEN in the burn intensive care unit with literature reviews.
METHODS

1) Patients
A retrospective review was performed on all 11 patients who visited our hospital burn center for SJS/TEN from January 2004 to December 2008. All of them were admitted to the burn intensive care unit.
2) Diagnostic criteria
Diagnoses were made by dermatologists with histopathological confirmation. The patients were divided into three groups according to the following criteria of Bastuji-Garin et al. (8, 9) . Bullous erythema multiforme (EM):
epidermal detachment involving ＜10% of the body surface, coupled with localized typical targets or raised atypical targets. SJS: epidermal detachment of ＜10% of the body surface in association with widespread erythematous or purpuric macules or flat atypical targets. SJS/TEN overlap: epidermal detachment of 10% to 30% of the body surface plus widespread purpuric macules or flat atypical targets. TEN with spots: epidermal detachment of ＞30% of the body surface coupled with wide spread purpuric macules or flat atypical targets. TEN without spots: large sheets of epidermal detachment involving ＞10% of the body surface without purpuric macules or target lesions.
3) Evaluations
Data regarding demographics, causative agents, pattern of involvement, underlying diseases, complications, mortality, and morbidity were obtained. As it is difficult to confirm which drugs are responsible for SJS/TEN, we checked all drugs used within 3 weeks of onset. were applied. Sulfonamide-containing topical agents were avoided. Antibiotics were applied only to treat systemic infections depending on the wound, urine, and blood cultures, which were checked twice a week. Steroids were prohibited and any steroid agents used prior to admission were discontinued. Ten patients in the burn intensive care unit were treated with intravenous immunoglobulin (IVIG) at a dose of 1 g/kg/day for 3 to 7 days (mean 4.3 days).
RESULTS
1) Demographics
A total of 11 patients (9 males and 2 females, mean age 31.81 years, range 5∼83 years) were included in this study.
According to the criteria of Bastuji-Garin et al., (8, 9) four patients were diagnosed with SJS/TEN (n=4, 36.36%) and seven with TEN (n=7, 63.64%). Six (54.55%) of the patients had underlying diseases, including hypertension, congestive heart failure, gout, nephritic syndrome, epilepsy, and glaucoma (Table 1) .
2) Medication history
The most common causative drugs were NSAIDs (6 of 11 patients, 54.55%) for upper respiratory infections. Two patients (18.18%) took allopurinol for gout. Two others had taken prednisolone for nephrotic syndrome. One (9.1%) (Table 1) .
3) Clinical courses
The time from appearance of the first skin lesions to the initiation of therapy varied from 1 to 10 days (mean 4.27 days). The mean period of hospital care to complete skin healing time was 9 days (8∼12 days). The mean period of hospitalization was 14.66 days (7∼22 days). All patients showed involvement of the mucous membranes, including the buccal, conjunctival, and genital mucosae.
4) Complications
During admission, coagulase negative staphylococcus, P. aeruginosa, A. baumannii, and methicillin-resistant staphylococcus aureus were cultured. On laboratory examination, neutropenia was found in three cases and normocytic anemia in six cases. The most common complication was hepatitis, which was seen in one case in the overlap SJS/TEN group and four cases in the TEN group. Acute renal failure occurred in four cases in the TEN group.
Continuous renal replacement therapy (CRRT) was applied in two patients. Two patients developed sepsis and three patients had disseminated intravascular coagulation (DIC).
Conjunctivitis developed in six patients.
5) Mortality and SCORTEN evaluation
Two of eleven patients died of septic complications with DIC due to TEN, resulting in a mortality rate of 18.18% (Table 2) . In two patients, acute renal failure and pneumonia were accompanied with a SCORTEN score of 5.
The mean SCORTEN score were 2.5 in the overlap SJS/ TEN group and 3.85 in the TEN group. Three patients had a score of 5. One patient had a score of 4. Four patients had as score of 3 and three patients had a score of 2 (Table 3 ). The number of expected deaths was 5.058, but the actual number of deaths was 2 (Table 4) . Compared to those previous studies, the burn intensive care unit treatment presents some positive points (Table 5) . Heart rate (＞120/min) Score 
